Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Investing in company. & entry points

<< Previous

Bullboard Posts

Next >>

Comment by drippingsnoton Aug 25, 2020 11:50pm

84 Views

Post# 31453652

RE:RE:RE:RE:RE:RE:Investing in company. & entry points

You'll be waiting for the next AGM vote to see if sentiment changes.
Management has no excuses for you.
They have extended their reach.
They will grow the product lines.

That's it - no fireworks.

The markets will do what the markets do.

<< Previous

Bullboard Posts

Next >>

Canadians having more difficulty saving for retirement, study finds